Real-World Outcomes of Patients Treated with Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Systematic Review and Meta-Analysis

被引：2
作者：
Cheung, Matthew C.
Amitai, Irina
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140577
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
[21]   Patterns of Lymphocytosis in Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Treated with Idelalisib [J].
Brown, Jennifer R. ;
Cheson, Bruce D. ;
Furman, Richard R. ;
Ghia, Paolo ;
Hallek, Michael ;
Hillmen, Peter ;
O'Brien, Susan M. ;
Sharman, Jeff P. ;
Dubowy, Ronald L. ;
Velasco, Barbara ;
Waldapfel, Christopher C. ;
Zelenetz, Andrew D. .
BLOOD, 2015, 126 (23)
[22]   Improved outcomes in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) treated with ibrutinib during earlier lines of therapy [J].
Munir, T. ;
Tedeschi, A. ;
Hillmen, P. ;
Woyach, J. ;
Byrd, C. ;
Ghia, P. ;
Mulligan, S. P. ;
Dai, S. ;
Amaya-Chanaga, C. ;
Dean, J. P. ;
O'Brien, S. M. ;
Barr, P. M. .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 :215-216
[23]   Real-world Comparison of Adherence Between Patients with Chronic Lymphocytic Leukemia Treated with Single-agent Ibrutinib or Acalabrutinib In First Line [J].
Lu Xiaoxiao ;
Bruno, Emond ;
Laura, Morrison ;
Frederic, Kinkead Frederic ;
Patrick, Lefebvre ;
Helene, Marie-Lafeuille ;
Wasiulla, Khan ;
Wu Linda ;
Zaina, P. Qureshi Zaina P. ;
Ryan, Jacobs .
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 :S26-S26
[24]   Real-World Bruton Tyrosine Kinase Inhibitor (BTKi) Utilization and Clinical Outcomes Among Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [J].
Hou, Jing-Zhou ;
Choksi, Rushir ;
Maglinte, Gregory A. ;
Uasudevan, Anupama ;
Rui, Anna ;
Wang, Brandon ;
Pham, Hoa ;
Lasn, Ann ;
Blanc, Simon .
BLOOD, 2024, 144 :2353-2354
[25]   Long-Term Efficacy and Safety of Single-Agent Ibrutinib at 3 Years Follow-up in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) [J].
O'Brien, Susan M. ;
Jones, Jeffrey A. ;
Furman, Richard R. ;
Coutre, Steven E. ;
Flinn, Ian W. ;
Burger, Jan A. ;
Blum, Kristie A. ;
Sharman, Jeff P. ;
Wierda, William G. ;
Zhao, Weiqiang ;
Heerema, Nyla A. ;
Johnson, Amy J. ;
Tran, Anh ;
Zhou, Cathy ;
Bilotti, Elizabeth ;
James, Danelle F. ;
Byrd, John C. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 :S206-S206
[26]   Real-World Outcomes with First-Line Ibrutinib (Ibr) Versus Chemoimmunotherapy (CIT) in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Final Analysis Results from the InformCLL Registry [J].
Ghosh, Nilanjan ;
Sharman, Jeff P. ;
Barrientos, Jacqueline C. ;
Brander, Danielle ;
Gutierrez, Meghan ;
Wu, Linda ;
Qureshi, Zaina P. ;
Upasani, Sandhya ;
Naganuma, Maoko ;
Mato, Anthony R. .
BLOOD, 2022, 140 :7047-7049
[27]   Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Analysis of 2028 patients [J].
Tsimberidou, A. M. ;
Wen, S. ;
O'Brien, S. ;
McLaughlin, P. ;
Wierda, W. G. ;
Kantarjian, H. ;
Lerner, S. ;
Strom, S. ;
Freireich, E. J. ;
Medeiros, L. ;
Keating, M. J. .
ANNALS OF ONCOLOGY, 2008, 19 :196-196
[28]   Real-World Outcomes for 205 Danish Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib [J].
Aarup, Kathrine ;
Enggaard, Lisbeth ;
Pedersen, Robert Schou ;
Thomsen, Rasmus Heje ;
Bergmann, Olav Jonas ;
Frederiksen, Mikael ;
Christiansen, Ilse ;
Nielsen, Tine ;
Frederiksen, Henrik ;
Niemann, Carsten Utoft ;
Andersen, Michael Asger .
BLOOD, 2019, 134
[29]   Real-World Clinical Outcomes of First-Line (1L) Ibrutinib Dose Reduction Versus Acalabrutinib Among Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) [J].
Shadman, Mazyar ;
Karve, Sudeep ;
Abbazio, Christopher ;
Majd, Zahra ;
Bacchus, Shaffee ;
Saifan, Chadi ;
Gogna, Priyanka ;
Manceur, Ameur M. ;
Lafeuille, Marie-Helene ;
Emond, Bruno ;
Srivastava, Bhavini P. ;
Stephens, Deborah M. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 :S352-S352
[30]   Unmutated IGHV is not an adverse predictor of outcome to therapy with ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) [J].
Kipps, Thomas J. ;
Fraser, Graeme ;
Coutre, Steven ;
Brown, Jennifer R. ;
Barrientos, Jacqueline C. ;
Barr, Paul M. ;
Byrd, John C. ;
O'Brien, Susan M. ;
Dilhuydy, Marie-Sarah ;
Devereux, Stephen ;
Jaeger, Ulrich ;
Moreno, Carol ;
Cramer, Paula ;
Stilgenbauer, Stephan ;
Chanan-Khan, Asher A. ;
Mahler, Michelle ;
Salman, Mariya ;
Cheng, Mei ;
Londhe, Anil ;
Ninomoto, Joi ;
Howes, Angela ;
James, Danelle ;
Hallek, Michael .
CANCER RESEARCH, 2017, 77
12345